Paraneoplastic syndromes affecting the central nervous system

Annual Review of Medicine

Volumn 48, Issue , 1997, Pages 157-166

  Posner, Jerome B ^a   Dalmau, Josep O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Autoantibodies; Cancer; Carcinoma; Paraneoplastic; Small cell lung cancer

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BETA INTERFERON; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN G; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TACROLIMUS;

CANCER; CENTRAL NERVOUS SYSTEM DISEASE; CHOLINERGIC SYNAPSE; EATON LAMBERT SYNDROME; HUMAN; IMMUNITY; INTRAVENOUS DRUG ADMINISTRATION; PARANEOPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

AUTOANTIBODIES; AUTOANTIGENS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; NEUROLOGIC EXAMINATION; PARANEOPLASTIC SYNDROMES; PROGNOSIS;

EID: 0031046847     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.48.1.157     Document Type: Review

References (35)

1. Posner JB. 1995. Neurologic Complications of Cancer. Philadelphia: Davis
2. Brain WR, Norris FH, eds. 1965. The Remote Effects of Cancer on the Nervous System. New York: Grune & Stratton
3. Jacobson DM, Thirkill CE. 1995. Paraneoplastic cone dysfunction: an unusual visual remote effect of cancer. Arch. Ophthalmol. 113:1580-82
4. Peterson K, Rosenblum MK, Kotanides H, et al. 1994. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody positive patients. Neurology 42:1931-37
5. Lang B, Newsom-Davis J. 1995. Immunopathology of the Lambert-Eaton myasthenic syndrome. Semin. Immunopathol. 17:3-15
6. Dalmau J, Graus F, Rosenblum MK, et al. 1992. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine 71:59-72
7. Darnell RB. 1996. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity and the brain. Proc. Natl. Acad. Sci. USA 93:4529-36
8. Henson RA, Urich H, eds. 1982. Cancer and the Nervous System: The Neurological Manifestations of Systemic Malignant Disease. London: Blackwell Sci.
9. Dalmau J, Furneaux HM, Rosenblum MK, et al. 1991. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 41:1757-64
10. Verschuuren J, Chuang L, Rosenblum MK, et al. 1996. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo associated paraneoplastic cerebellar degeneration. Acta Neuropathol. 91:519-25
11. Anderson NE, Budde-Steffen C, Rosenblum MK, et al. 1988. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine 67:100-9
12. Ridley A, Kennard C, Scholtz CL, et al. 1987. Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain 110:1699-709
13. Fukuoka T, Engel AG, Lang B, et al. 1987. Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones. Ann. Neurol. 22:1993-99
14. Pranzatelli MR. 1995. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin. Neuropharmacol. 18:1-47
15. Todorov P, Cariuk P, McDevitt T, et al. 1996. Characterization of a cancer cachectic factor. Nature 379:739-42
16. Rosenfeld MR, Posner JB. 1991. Paraneoplastic motor neuron disease. In Advances in Neurology, Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases, ed. LP Rowland, 56:445-59. New York: Raven
17. Sekido Y, Bader SA, Carbone DP, et al. 1994. Molecular analysis of the HuD gene encoding a paraneoplastic encephalomyelitis antigen in human lung cancer cell lines. Cancer Res. 54:4988-92
18. Dalmau J, Graus F, Cheung NK, et al. 1995. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75:99-109
19. Russell DS. 1961. Encephalomyelitis and carcinomatous neuropathy. In The Encephalitides, ed. L van Bogaert, J Radermecker, J Hozay, A Lowenthal, pp. 131-35. Amsterdam: Elsevier
20. Furneaux HM, Reich L, Posner JB. 1990. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40:1085-91
21. Dalmau J, Furneaux HM, Cordon-Cardo C, Posner JB. 1992. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues. Am. J. Pathol. 141:881-86
22. Posner JB, Dalmau J. 1996. Neurological paraneoplastic syndromes: a review of diagnosis and prospects for therapy. J. Clin. Neurosci. 3:8-15
23. Cher LM, Hochberg FH, Teruya J, et al. 1995. Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cancer 75: 1678-83
24. Uchuya M, Graus F, Vega F, et al. 1996. Intravenous immunoglobulin therapy in paraneoplastic neurologic syndromes with anti-neuronal autoantibodies. J. Neurol. Neurosurg. Psychiatr. 60:388-92
25. Graus F, Vega F, Delattre J-Y, et al. 1992. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42:536-40
26. Altman AJ, Baehner RL. 1976. Favorable prognosis for survival in children with co-incident opso-myoclonus and neuroblastoma. Cancer 37:846-52
27. Cohn SL, Salwen H, Herst CV, et al. 1988. Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus. Cancer 62:723-26
28. Hetzel DJ, Stanhope CR, O'Neil BP, et al. 1990. Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-Purkinje cell antibodies and limited in metastatic volume. Mayo Clin. Proc. 65: 1558-63
29. Posner JB, Malats N, Rene R, et al. 1996. Anti-Hu antibodies as a prognostic marker for SCLC response to therapy. J. Invest. Med. 44:234 (Abstr.)
30. Hammack J, Kotanides H, Rosenblum MK, et al. 1992. Paraneoplastic cerebellar degeneration: II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology 42:1938-43
31. Mason WP, Graus F, Valldeoriola F, et al. 1996. Paraneoplastic cerebellar degeneration in small cell lung cancer: impact of anti-Hu antibody on clinical presentation and survival. Neurology 46:127 (Abstr.)
32. Luque FA, Furneaux HM, Ferziger R, et al. 1991. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann. Neurol. 29:241-51
33. Carr I. 1982. The Ophelia syndrome: memory loss in Hodgkin's disease. Lancet 1: 844-45
34. Polans AS, Witkowska D, Haley TL, et al. 1995. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc. Natl. Acad. Sci. USA 92:9176-80
35. De Camilli P, Thomas A, Cofiell R, et al. 1993. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of Stiff-Man syndrome with breast cancer. J. Exp. Med. 178:2219-23